Matthew K Fust Neumora Therapeutics, Inc. (NMRA) insider trading activity

Shares Held (Direct Ownership) 20.1K

0% 3M change

n/a 12M change

Total Value Held N/A

Matthew K Fust Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 18 2024	SELL Open market or private sale	$239,254 $17.03 p/Share	14,049 Reduced 41.14%	20,100 Common Stock
Oct 18 2024	BUY Exercise of conversion of derivative security	$79,517 $5.66 p/Share	14,049 Added 29.15%	34,149 Common Stock
Oct 17 2024	SELL Open market or private sale	$131,640 $17.01 p/Share	7,739 Reduced 27.8%	20,100 Common Stock
Oct 17 2024	BUY Exercise of conversion of derivative security	$50,613 $6.54 p/Share	7,739 Added 21.75%	27,839 Common Stock
Jun 13 2024	BUY Grant, award, or other acquisition	-	20,100 Added 50.0%	20,100 Common Stock

CRNX

Crinetics Pharmaceuticals, Inc. Healthcare

ATRA

Atara Biotherapeutics, Inc. Healthcare

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

MKF

San Diego, CA

Receive a notification when an Institution or Guru buys or sells NMRA shares.

Notify only if

Value

Get notified when an Neumora Therapeutics, Inc. insider buys or sells NMRA shares.

Notify only if

Operation

Value

Type

Receive news related to Neumora Therapeutics, Inc.